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          ABSTRACT 
 
M. tuberculosis is the causative agent of a global health epidemic that kills ~1.5 million 
people each year.  The outcomes of infection with Mtb are highly variable.  Although many 
patients are able to control the infection in a quiescent state, others develop active disease.  
Furthermore, the progression of TB lesions has been shown to vary within a single individual.  
This phenotypic variability in the infecting population of Mtb may be responsible for the high 
rate of treatment failures, which can exceed 20% in some endemic areas (World Health 
Organization, 2015).  Although genetic mutation can drive a portion of the observed phenotypic 
variability, mutation rates in mycobacteria are exceedingly low.  Epigenetic factors are therefore 
likely to be responsible for the majority of observed diversity in infection and treatment 
outcomes.   
Here, we investigated epigenetic drivers of phenotypic variability and survival in 
mycobacteria.  We found evidence of high rates of phenotypic variability in response to drug 
treatment of M. smegmatis, a non-pathogenic, model for TB.  Specifically, we found that two 
distinct subpopulations are able to grow in the presence of drug.  These subpopulations exhibited 
heritability of their transcriptional profiles, growth properties, and ability to grow on drug across 
generations.  We next found that hupB, a histone-like protein, is critical for the formation of 
these epigenetically regulated subpopulations.  We also show that hupB regulates gene 
expression and is post-translationally modified, and that modification of hupB may drive the 
formation of one of these phenotypically drug-resistant subpopulations.  These findings suggest 
that modification of a histone-like protein may drive epigenetic inheritance and phenotypic 
! "#!
variability in mycobacteria, which allows it to withstand antibiotic treatment. Finally, we also 
investigated alternative post-transcriptional mechanisms of hupB regulation. 
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CHAPTER ONE: INTRODUCTION 
1.1!The Global burden of tuberculosis 
Tuberculosis is a chronic respiratory illness that kills approximately 1.5 million people per 
year, causing the most fatalities of any infectious disease worldwide.  Infection with TB occurs 
when M. tuberculosis, the causative agent, is inhaled and taken up by alveolar macrophages.  
Immune cells aggregate around the infected macrophages, which forms a granuloma, a lesion 
which can block the airway and produce the primary symptom of TB, the chronic cough.  The 
majority of those infected with TB are able to effectively control the infection, while about ten 
percent of them develop active disease.  It has been estimated that nearly a third of the world’s 
population is latently infected with Mtb. Immunocompromising factors such as HIV can 
accelerate the risk of reactivation of these latent infections. 
1.2 Treatment of TB 
Treatment of TB involves a four drug regimen that is taken over a period of up to nine  
months.   The long treatment time is designed to reduce the risk of drug resistance and sterilize 
the infection.  Still, incomplete treatment is a common source of treatment failure, and even in 
successfully treated cases, recurrent infections are common and may occur in up to ~30 percent 
of patients (Cox et al., 2006).  Among recurrent infections, roughly half are due to relapse of the 
primary infection, rather than reinfection with a different strain (Bryant et al., 2013), Richa 
Gawande, unpublished data).   Notably, relapse after completed treatment can occur in the 
absence of an underlying genetic mutation, implying that epigenetic factors may drive treatment 
failure in a portion of cases.  Furthermore, biphasic killing of Mtb in patients in response to 
antibiotic treatment has been observed, suggesting that subpopulations of drug-tolerant bacteria 
may cause treatment failures (Figure 1.1, (Jindani, Doré, & Mitchison, 2003; Walter et al., 2015).  
! &!
Understanding the factors that drive these variable infection and treatment outcomes is crucial to 
improving the control of this epidemic.  
 
Figure 1.1. (Jindani et al., 2003) Bactericidal activities of antibiotics within the first 14 days 
following treatment. African patients with previously untreated, smear-positive, drug-sensitive 
TB were studied. Drugs were given daily and sputum was collected at indicated time points 
following the start of treatment. H= isoniazid only, R- rifampin only, HR – isoniazid and 
rifampin. 
 
1.3 Phenotypic diversity in TB infection  
Mtb has a limited capacity to create genetic diversity.  Unlike many other bacteria, Mtb does 
not possess the machinery to undergo horizontal gene transfer.  The mutation rate of Mtb is also 
exceedingly low, with estimates hovering around 2.4 x 10-10 mutations per base pair per 
generation.  Still, the extent of phenotypic variability in Mtb has recently begun to be 
appreciated.  A recent study elucidated the role of this variability in driving variable infection 
outcomes.  Infection of a macaque with a clonal population of Mtb will result in both sterile and 
active granuloma lesions within a single animal (Figure 1.2, (Lin et al., 2014).  These lesions can 
be founded by just one or a few bacteria, suggesting that diversity in the infecting bacterial 
population may drive the variable lesion outcomes within a person, and perhaps also the variable 
clinical outcomes observed between individuals and in response to antibiotic treatment.  
! '!
 
Figure 1.2. The coexistence of sterile and active lesions within a single macaque (Lin et al., 
2014). A) Tracking of 2 lesions over time within a single monkey.  B) Percentage sterile lesions 
per animal – monkeys with both clinically active and latent disease exhibit lesions with a wide 
range of sterilizing activity. 
   
 
1.4 Phenotypic diversity in response to antibiotics 
Exposing bacterial populations to antibiotics in vitro frequently reveals the extent of 
phenotypic diversity in bacterial populations.  Distinct subpopulations with phenotypes 
beneficial for survival can be selected for in the presence of drug. The first example of 
phenotypic diversity influencing the survival of bacteria in the presence of drug was described by 
Joseph Bigger in 1944.  Bigger observed that upon exposure of a clonal population of bacteria to 
high concentrations of antibiotic, a fraction of cells would survive treatment.  These cells, which 
he termed persisters, did not posses high-level genetic resistance, as evidenced by the fact that 
upon regrowth in media without drug and re-exposure, the progeny of the persisters exhibited the 
same susceptibility to drug as the starting population.  Bigger hypothesized that that these cells 
were a subpopulation of non-dividing cells that could withstand antibiotic treatment due to their 
! (!
halted growth.  Sixty years later, Bigger’s hypotheses were validated.  Using high persistence 
forming strains of E.coli, individual persister cells were imaged before and after antibiotic 
treatment.  Persisters were shown to be generated from both non-dividing and slowly growing 
cells that were pre-existing in the population (Balaban, Merrin, Chait, Kowalik, & Leibler, 
2004).  
Since the discovery of persisters, more recent studies have shown that a variety of 
phenotypically distinct subpopulations with differential susceptibilities to antibiotics can exist 
within a clonal bacterial population(Dhar & McKinney, 2007; Kester & Fortune, 2014). 
Although persisters generally represent an antibiotic-tolerant subpopulation with slow or 
nonexistent growth, a wide spectrum of growth rate heterogeneity in bacterial populations has 
since been demonstrated. In mycobacteria, using an rRNA reporter to report on the relative 
growth rates of individual cells, Manina et al showed that there is variability in growth rates 
across single cells under standard conditions and that this variability increases in the presence of 
drug and after host infection(Manina, Dhar, & McKinney, 2015). Actively growing persister 
cells were also identified in mycobacteria, suggesting that antibiotic tolerant subpopulations 
could be drawn from cells with a range of growth rates (Wakamoto et al., 2013).   
1.5 Molecular mechanisms driving phenotypic diversity 
Although phenotypic diversity in bacterial populations has been widely described, the 
known molecular mechanisms underpinning the formation and maintenance of these 
subpopulations are still scarce.   The finding that mycobacteria grow and divide asymmetrically 
offered a significant advance to our understanding of how distinct cell types with differential 
antibiotic susceptibilities could arise from a clonal population (Aldridge et al., 2012).   
Asymmetric growth produced faster-growing cells, termed accelerators, which were more 
! )!
susceptible to cell-wall acting drugs, and slower growing cells, which were more susceptible to 
rifampicin, a transcription targeting drug (Aldridge et al., 2012). 
 Differential gene expression is a common strategy that can also create phenotypic 
variants with different drug susceptibilities.  HipA, a toxin that alters bacterial growth, was 
identified as a crucial mediator of persistence in a screen for high-persistence mutants.  Later 
studies showed that variable expression of hipA in subsets of cells may underlie their persister 
phenotype.  Binding of the hipA toxin to its cognate antitoxin can also vary across individual 
cells.  The nonlinear binding kinetics of toxin/antitoxin interactions could result in threshold 
based amplification of variability in the toxin phenotypes across cells (Balaban, 2011).  Variable 
expression of other genes, including virulence factors and efflux pumps, has also been linked to 
altered drug susceptibilities in subsets of cells(Adams et al., 2011; Arnoldini et al., 2014; 
Sánchez-Romero & Casadesús, 2014).  In mycobacteria, stochastic pulsing of katG correlated 
with survival of single cells in the presence of INH (Wakamoto et al., 2013), raising the 
intriguing possibility that gene expression variability at relatively short time scales could drive 
differences in drug susceptibilities. 
Bistable expression of genes in a bacterial population can be established and maintained 
by a combination of noise and positive feedback loops. Noisy gene expression creates cells with 
different expression levels of a certain gene. When gene expression passes a certain threshold in 
a given cell, a positive feedback loop can be initiated, where the gene amplifies its own 
expression.  This positive feedback results in at least two subpopulations of cells, with high and 
low expression of a given gene.  Positive feedback loops can be maintained across generations, 
resulting in a heritable, bistable phenotype.  Classic examples of bistability regulated by positive 
feedback loops are competence development in Bacillus subtilis and induction of the lac operon 
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in E. coli.  More recently, expression of relA, the mycobacterial stringent response regulator, was 
also shown to be bimodally distributed and governed by noise and a positive feedback 
loop(Sureka et al., 2008).  Growth rate feedback onto gene expression can also promote and 
maintain distinct subpopulations of cells (Kiviet et al., 2014).  Finally, DNA methylation can 
drive differential gene expression in subsets of cells, as in the pap switch in E. coli.  
1.6 Overview of chapters 
 In this dissertation we investigated epigenetic drivers of phenotypic variation and 
survival in mycobacteria. In Chapter 2, we imaged M.smegmatis colonies growing in the 
presence of drug and find that two distinct colony types appear in the presence of drug.  These 
colony types consisted of two distinct subpopulations of cells with different transcriptional 
signatures and growth properties that were heritable across generations.  Furthermore, these cells 
were heritably drug resistant, such that they retained their increased ability to grow on drug even 
after expansion in media without drug, suggesting that they comprise a fundamentally distinct 
population from the canonically described persister cells.  In Chapter 3, we found that a 
nucleoid associated protein, hupB, may drive the formation of both populations of epigenetically 
regulated drug resistant variants. We also investigate the function of posttranslational 
modification of hupB and find that mutation of a hupB methylation site specifically abrogates the 
formation of one of these subpopulations.  This finding suggests that bacteria may be able to 
heritably alter their nucleoid structure to affect gene expression in subpopulations cells and 
thereby create cells with distinct phenoytpes, akin to the use of histone modification in 
eukaryotes.  Lastly, in Chapter 4, we investigate alternate mechanisms by which hupB function 
might be regulated in response to fluctuating environments. 
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2.1 Abstract 
Phenotypic variants of bacterial cells within a clonal population typically persist upon exposure 
to antibiotics despite the sensitivity of their genetically identical brethren.  The persistence of 
these subpopulations may be responsible for the slow eradication of bacterial infections such as 
Mtb in response to antibiotic treatment.   A hallmark of these non-genetically determined 
survivors of drug exposure has historically been the lack of stable inheritance of the drug 
resistance phenotype across multiple generations.  Here, using high-throughput quantitative 
plating and dynamic imaging, we identified novel mycobacterial subpopulations that exhibit 
heritable, epigenetically determined drug resistance which allows them to grow in the presence 
of antibiotic. We show that at least two distinct epigenetically regulated lineages of bacteria 
thrive in the presence of drug.  These two subpopulations have distinct growth rates and 
transcriptional signatures that are heritable across generations.  
 
 
 
 
 
 
 
 
 
 
 
! -!
2.2 Introduction 
Phenotypic diversity in bacterial populations is a key barrier in the design of effective 
antibiotics.  Antibiotic treatment failure has historically been attributed to a subpopulation of 
nongrowing cells, termed persisters.  However, more recent studies have identified subsets of 
cells that continue to divide in the presence of antibiotic, and these actively growing subsets of 
cells may in fact be responsible for the slow eradication of bacterial infections after antibiotic 
therapy ((Adams et al., 2011; Claudi et al., 2014; Wakamoto et al., 2013))(Walter et al., 2015). A 
hallmark of these phenotypic variants that withstand drug treatment has historically been the lack 
of stable inheritance of the drug resistance trait. Upon re-growth in media without drug, the 
resulting progeny are killed with the same kinetics as the starting population.  Nonetheless, 
dynamic persistence appeared to track between sister cells, suggesting that epigenetic inheritance 
may play a role in the survival of these actively growing subpopulations(Wakamoto et al., 2013). 
This growing body of evidence suggests that the subpopulations of cells that survive in the 
presence of drug may be more diverse and dynamic than originally thought. Understanding the 
subpopulations of cells that can withstand antibiotic treatment is crucial to improving the design 
of future therapies.   
Non-growing persisters have been challenging to enrich and characterize due to their 
rarity in the populations and their inability to divide in the presence of drug.  In contrast, actively 
growing, phenotypically drug resistant subpopulations of cells could theoretically be selected for 
and enriched in the presence of drug.  We employed an adaptation of a previously established 
high-throughput quantitave dynamic imaging technique to identify and characterize 
mycobacterial subpopulations that grow in the presence of drug (Levin-Reisman et al., 2010). 
Using this technique, we monitored growth of M. smegmatis in the presence of a range of 
! %.!
isoniazid (INH) concentrations.  We found that the numbers of colonies formed in the presence 
of drug dropped sharply at the beginning of the concentration range and then fell more slowly at 
increasing concentrations, consistent with the selection of drug resistant subpopulations.  We 
characterized these drug resistant subpopulations and found that at least two distinct 
subpopulations grow in the presence of drug. These two subpopulations, termed large and small 
variants, have distinct transcriptional signatures and growth properties.  Strikingly, these 
subpopulations of cells exhibited stable epigenetic inheritance of their growth properties and 
drug resistance across generations. 
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2.3 Results 
Identification of mycobacterial subpopulations that grow in the presence of drug 
To identify subpopulations of mycobacteria that grow in the presence of drug, we used an 
adaptation of the ScanLag technique, established by Nathalie Balaban, which combines plating 
with high-throughput dynamic imaging to identify rare bacterial growth variants(Levin-Reisman 
et al., 2010).  We grew an isogenic population M. Smegmatis in rich media without drug, and 
then plated aliquots of the cultured cells on agar plates containing an increasing gradient of drug 
concentrations (Fig 1A). We reasoned that if, in the presence of drug, the entire population were 
growing slowly, all the cells plated would form colonies slowly at the same time.  Alternatively, 
if privileged subpopulations of cells were growing more rapidly, a subset of colonies would 
come up earlier.  We observed the latter- as drug concentration increased, a subset of the cells 
plated formed colonies, implying that the inhibition of growth observed at the population level at 
MIC levels of drug is actually due to a mixture of bacterial cells with different growth properties 
and drug susceptibilities, consistent with what others have found at higher drug concentrations 
(Fig.1B) (Wakamoto et al, 2013).   Surprisingly, we observed that at ~MIC levels, the colonies 
came up at two distinct time points, suggesting that two distinct cell lineages are preferentially 
thriving in the presence of drug (Fig1C,D).  The bimodal distribution of colony size observed at 
the final time point further supported this notion (Fig1C,E).  The high rate at which these 
colonies arose (5-10% of the populations) argues against a mutational mechanism for their 
formation. 
!  
  
 
! %&!
 
 
Figure 2.1 Identification of mycobacterial subpopulations that grow in the presence of 
drug. A) Schematic of experiment B) Number of colonies formed after plating on indicated 
concentrations of INH C) Time of initial detection of colonies in the presence and absence of 4 
ug/ml INH. D) Example series of one plate tracked over time by cell profiler (4ug/ml INH).  
Plates were run through custom program (Supp fig 1) and colored circles indicate the actual size 
of the detected colonies. E) Histogram of major axis length of colonies for all colonies plated, 
over time. (4ug/ml INH) 
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Variants have distinct growth properties 
The observation that the small and large colony variants come up at different times and grow to 
different sizes suggests that either, 1) the founding cells of the different colony types have 
different lag times, or 2) heritable differences in growth kinetics between the cells making up the 
colonies exist in the presence of drug (figure 2.2). To distinguish between these hypotheses, we 
picked individual large and small colonies and replated them on plates without drug.  We found 
that upon initial replating, cells from small colonies produced more small colonies than cells 
from large colonies, implying that the different colony phenotypes are comprised of distinct 
subpopulations of cells.   To further test this hypothesis directly at a single cell level, we grew 
cells from large and small colony variants in a microfluidic device with 4ug/ml and monitored 
their growth over ~48 hours.  We found that cells from large colonies were larger and had shorter 
division times than cells from small colonies.  
 
 
 
 
 
 
 
 
 
 
 
! %(!
 
Figure 2.2 Alternative models for small colony formation. In the first model, the founding 
cells of the SCVs have a longer lag time than those of the LCVs, once they start dividing, the 
resulting progeny is identical to the LCV.  In the second model, the SCVs are comprised of cells 
that heritably grow slower than the cells in the LCVs.  
! %)!
 
Figure 2.3. Variants have distinct growth properties.  A and B) LCVs and SCVs were picked 
from INH plates, resuspended in 7h9 media and replated onto plates without drug.  The 
histograms of the resulting colony sizes from each colony type after immediate replating (A) and 
after 96 hours in culture (B) are shown. C,D,E, and F) Large and small colonies were picked 
from INH plates and cells were loaded into a microfluidic device and imaged for ~48 hours. C) 
Images of one LCV cell over time, D) Images of one SCV cell over time E) Quantification of 
cell size at birth F) Quantification of time from birth to division for individual cells. 
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Phenotypic drug resistance is heritable, semi-stable 
The rate at which colonies appear on the drug plate is significantly higher (~5-10% of the 
population) than would be expected given a mutational mechanism.   However, the observation 
of colony-level phenotypes suggests that there is a stable, heritable determinant of drug 
resistance and growth variants.  To determine the stability of the drug resistant phenotype, we 
picked small and large variants and re-plated them on drug immediately (t=0) and at staggered 
time points following outgrowth in rich media without drug.  We found that phenotypic drug 
resistance was semi-heritable. Upon immediate re-exposure to antibiotics, the progeny exhibited 
significantly increased resistance compared to the original population.  This increased resistance 
gradually decreased after regrowth in rich media without drug, implying a semi-heritable 
mechanism of drug resistance in the presence of sublethal antibiotic (Figure 2.4, A).  One 
explanation for the observed stability of the phenotypic drug resistance could be that the cells 
failed to grow and divide upon reculturing in rich media, thereby allowing the cells to retain their 
previously acquired adaptation to drug.  We show that in fact upon reculturing of the large and 
small colonies in rich media, they begin growing and dividing within the first 24 hours (Figure 
2.4, B). We also measured growth at a single cell level after culturing in media without drug 
found that all cells went through 3-6 division cycles in the first 24 hours, further confirming that 
lack of growth does not explain the persistence of the drug resistance phenotype (data not 
shown). 
 The high rate (5-10% of the population) at which these colonies form in the presence of 
drug argues against a mutational mechanism for their formation.  To determine whether genetic 
mutations may underlie the colony phenotypes, we picked individual large and small colonies 
from a single plate and cultured them in liquid media without drug, and then did whole-genome 
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sequencing on the genomic extracts.  We found that one of the three small colony variants had a 
mutation in a beta-lactamase gene, and two of the three large colony variants had a mutation in a 
tetR transcriptional regulator.  These results suggest that although some of the colonies we see 
may be genetic mutants, genetic mutation is not a requirement per se for the establishment of the 
small and large colony phenotypes.  We also sequenced pools of small and large colonies in 
triplicate and did not find any mutations that uniquely associated with either small or large 
colonies.   
It is also a possibility that the two large colonies with the same mutation were sister cells.  
To control for the possibility of isolating sister cells in future experiments, we can plate 
independent cultures on INH plates and sequence colonies formed from the individual cultures. 
 
 
 
 
 
 
 
Figure 2.4.  Phenotypic drug resistance is heritable, semi-stable. A) Small colonies were 
picked, resuspended in liquid media and plated immediately (t=0) and then passaged through 
liquid media without drug and plated at indicated time points. Ratio of colonies on INH plates / 
plates without INH were measured. SP, starting population B) Stable drug resistance after 24 
hours is not due to stagnant growth after culturing of small colonies: Cfu counts after reculturing 
large and small colonies in liquid media. 
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Colony SNP  Base pair 
change 
GENE 
Large-1 None na na 
Large-2 801144 G>C MSMEG_0712 
Large-3 801144 G>C MSMEG_0712 
Small-1 2522298 C>T MSMEG_2439 
Small -2 None na na 
Small -3 None na na 
 
Table 2.1. Whole genome sequencing results.  Individual small and large colonies were picked 
in triplicate from INH plates and grown overnight in liquid media.  Whole-genome sequencing 
was performed on genomic extracts.   
 
 
 
 
Variants have distinct transcriptional signatures. 
 
We hypothesized that transcriptional differences may underlie the distinct growth properties of 
the cells forming large and small colonies.  To test this hypothesis, we pooled collections of large 
and small colonies in duplicate and did RNA-seq to compare transcriptional profiles of the two 
cell types.  We found evidence of extensive transcriptional differences between the large and 
small colony variants (Figure 2.5).  The data suggest that global downregulation of gene 
expression may drive the slow growth of the small colonies. 533 genes were found to be 
significantly downregulated (p<.01, foldchange>2) in the small colonies, including ~20 genes 
that were downregulated more than 10 fold.  We performed pathway enrichment analysis of the 
downregulated genes using DAVIDtools, and found that genes involved in transcription 
regulation were significantly enriched among the downregulated genes, further implicating a 
general reduction of transcriptional activity with the formation of the small colony variant 
phenotype (Figure S1). 
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 The existence of widespread transcriptional differences between the small and large 
colonies suggests that perhaps structural remodeling of the nucleoid is occurring in the distinct 
variant forms.   If structural changes were driving the observed differences in gene expression, 
we would expect that the chromosomal position of a gene would affect its transcriptional state.  
In fact, the distribution of differentially expressed genes across the genome appears nonrandom, 
such that neighboring genes are significantly more likely to be similarly regulated, even after 
excluding gene pairs that exhibit operonic structure (data not shown).  Nucleoid remodeling has 
been shown to regulate transcription in other bacteria (Kar, Edgar, & Adhya, 2005; Weng & 
Xiao, 2014).  In eukaryotic cells, chromatin states can be inherited across generations, and can 
drive the formation and maintenance of phenotypically diverse subpopulations.  The ability to 
inherit a particular nucleoid structure across generations would offer a novel mechanism by 
which bacteria could similarly form and maintain phenotypically distinct subpopulations of cells.   
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Figure 2.5. Variants have distinct transcriptional signatures.!Pools of large and small 
colonies were collected in duplicate, RNA was extracted from samples and RNA-seq libraries 
were made and sequenced.  A) Volcano plot of RNAseq results.  B) qPCR validation of genes 
differentially expressed in small and large colonies. 
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2.4 Discussion 
 
Chronic bacterial infections are notoriously difficult to clear, and epigenetic factors are 
likely to be responsible for many treatment failures(Bryant et al., 2013).  In Mtb, a biphasic 
response to antibiotic treatment has been observed in patients over time, where roughly 90% of 
bacteria are killed within the first two days post-treatment, while the last 10% percent of the 
population exhibits a significantly slower rate of kill (Figure 1.1)( (Jindani et al., 2003; Walter et 
al., 2015).  The recalcitrance of this subpopulation to antibiotics is thought to be partially 
responsible for the extended treatment period for Mtb, which can last from 6-9 months(Jindani et 
al., 2003).  The makeup of this slowly eliminated drug tolerant subpopulation is largely 
unknown, though transcriptional adaptation has been hypothesized to play a role(Jindani et al., 
2003).  Here we show that treating M. smegmatis with INH results in a biphasic kill curve with 
similar kinetics.  We find that this biphasic killing is due to the selection of two distinct, 
epigenetically regulated lineages of bacteria, that continue to grow in the presence of drug. 
Selection of these actively growing lineages in vivo could delay the eradication of Mtb infection 
and increase the likelihood of developing drug resistance. 
Variable colony phenotypes have previously been observed in response to stressors in 
other organisms.  Small colony variants (SCVs) in Staphylococcus aureus were first discovered 
in the early 1900s.  Interest in them increased in the last couple decades due to growing evidence 
that SCVs are associated with chronic, persistent infections which are notoriously difficult to 
treat(Kahl, 2014; Proctor et al., 2006).  SCVs have since been identified in other bacteria, 
including Pseudomonas aeruginosa.  Still, the term SCV is descriptive, and the mechanisms 
underlying their formation are diverse.  A variety of in vitro and in vivo stress conditions have 
been shown to create the small colony phenotype, ranging from intracellular infection to 
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exposure to cold temperatures and low pH(Leimer et al., 2016; Mirani, Aziz, & Khan, 2015; 
Tuchscherr et al., 2011).  The SCVs that have been identified under these array of conditions 
have fallen into two broad classes : 1) stable SCVs that do not revert to the normal colony 
phenotype upon subculture, and are caused by an underlying genetic mutation, and 2) nonstable 
SCVs that rapidly revert to the normal colony phenotype upon subculturing.   Stresses such as 
antibiotics and starvation have been shown to increase lag times of individual cells (Fridman, 
Goldberg, Ronin, Shoresh, & Balaban, 2014).  Therefore, it has remained unclear whether these 
nonstable SCVs are formed by a founding cell population with increased lag times, or if the 
SCVs are comprised of a lineage of cells that heritably grow differently in the presence of the 
applied stress (Figure 2.2).  These two alternative models imply starkly different underlying 
mechanisms and biological consequences, and thus discriminating between them is essential to 
improve our understanding of bacterial survival strategies. 
In our work, we used a combination of high-throughput dynamic and quantitative 
imaging to identify and define mycobacterial subpopulations that are able to grow in the 
presence of sublethal antibiotics.  We found that two colony phenotypes appeared in the presence 
of drug, which we termed large and small colony variants.  Using a combination of live-cell 
imaging, rna-seq, and whole-genome sequencing, we determined that these subpopulations have 
distinct transcriptional profiles and growth properties that are heritable across generations and 
cannot be explained by underlying genetic mutations.  Remarkably, these phenotypic variants 
exhibited a heritable ability to grow on drug.  Following regrowth in media without drug, the 
progeny of these variants showed increased resistance to drug relative to the original population 
even after 24 hours of subculture, after which drug resistance gradually returned to the level of 
the original population.  Variant types could also be distinguished from each other after initial 
! &'!
subculturing, further indicating that the variant forms are heritable across generations. Live-cell 
imaging confirmed that heritable differences in growth dynamics between the variant types could 
be also be detected at a single-cell level.  These findings show that phenotypically drug resistant, 
epigenetically regulated lineages of mycobacteria are selected for in the presence of sublethal 
antibiotics.   
Our experiments do not formally determine whether these subpopulations are pre-existing 
in the population or whether they arise de novo in the face of drug treatment.  The high rate at 
which we detect these resistant populations in the presence of drug (up to 10% of the population) 
suggests that drug is at least increasing the capacity of the bacteria to form these variants, 
however future experiments must be done to discriminate between these possibilities. 
Although here we used M. smegmatis and sublethal antibiotics to isolate these phenotypic 
variants, colony size variation has been observed in mycobacteria in a variety of conditions.   
Notably, small and large colonies have been observed after plating M. tuberculosis from 
macrophages and mice (data not shown).  Accordingly, single cell variation has been observed in 
M. tuberculosis in response antibiotic and immune stress(Manina et al., 2015). One study used an 
rRNA fluorescent reporter in M. tuberculosis  as a measure of the growth rates of single 
mycobacterial cells, and found that variation in reporter levels across individual cells increased 
in response to drug and immune stress (Manina et al., 2015). Reporter levels also correlated 
between mother and daughter cells, suggesting a possible role epigenetic inheritance.  These 
findings together with our work suggest that perhaps small and large colony variants may be 
privileged, epigenetically regulated subpopulations that are selected for under a variety of 
conditions and contribute to the relcalcitrance of Mtb to immune control and antibiotic treatment. 
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2.5 Materials and Methods 
Plating assay 
M. smegmatis cultures were started from individual colonies in triplicate and grown to stationary 
phase (approx. 2 days).  Cultures were then normalized, back diluted and grown to an OD ~1.0.  
Cultures were then diluted from between 10e-3 to 10e-5 and 100ul aliquots were plated on 7h10 
plates supplemented with OADC (Middlebrook) and 20%tween80 (2.5%).  Isoniazid was diluted 
in water at 5mg/ml and added to plates at indicated concentrations.  Plates were incubated at 37 
degrees Celsius for 4-6 days. Plates were imaged at defined time points following plating, using 
an Android camera phone.  Plate images were analyzed using a custom cellprofiler pipeline to 
count and size colonies (sup fig).   
Live cell imaging 
Small and large colonies were picked from 7h10 plates with 4ug/ml INH, and resuspended in 
1ml 7h9 supplemented with OADC (Middlebrook) and sonicated.  Cells were loaded onto a 
microfluidic device and images were acquired every 10 min for 48 hours. 
Reversion assays 
Small and large colonies were picked from 7h10 plates with 4ug/ml INH, resuspended in 1 ml 
7h9 supplemented with OADC (Middlebrook), sonicated, diluted from 10e-1 to 10e-5 and 100 ul 
aliquots were plated on 7h10 plates with and without INH.   Resuspended cells were grown in 5 
ml 7h9, incubated at 37 degrees with shaking, and replated using above methods at defined time 
points. 
RNAseq experiments 
Cells were harvested and resuspended in 1 ml Trizol, and bead beat 2x on a RNA was extracted 
using Directzol columns (Zymo Research) and ribosomal RNA was removed using the magnetic 
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RiboZero-Bacteria kit (Illumina).  Libraries were prepared with the KAPA mRNA-seq kit, and 
sequenced on the MiSeq (Illumina). 
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Supplementary Figure 2.1.  Enrichment analysis results of genes downregulated in small 
colonies. Genes downregulated more than 2 fold with a p value <.01 were entered into 
DAVIDtools functional enrichment analysis program (533 genes total).  Count: number of genes 
annotated in given category. Bonferoni: statistical significance of enrichment of functional 
category. 
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Supplementary Figure 2.1.  Enrichment analysis results of genes downregulated in small 
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Supplementary Figure 2.1.  Enrichment analysis results of genes downregulated in small 
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3.1 Abstract  
 
Phenotypic heterogeneity is a common bet-hedging strategy used by bacteria to maximize the 
likelihood of survival in a variety of conditions.  In chapter 2, we demonstrated a form of 
phenotypic diversification in M. smegmatis that creates at least two subpopulations of bacteria 
that grow in the presence of drug.  These subpopulations have distinct transcriptional profiles 
and growth properties that are heritable across generations in the absence of an underlying 
genetic mutation.  In this chapter, we describe a novel epigenetic mechanism that may drive the 
formation of these mycobacterial subpopulations.  We show that the mycobacterial histone-like 
protein, hupB, is required for the formation of both subpopulations to grow in the presence of 
drug.  We found that hupB is modified in M. smegmatis and M. tuberculosis in a whole cell 
proteomics screen, and we validated the modification sites with purified hupB.  To study the 
function of these modification sites, we made a series of hupB mutants to abrogate modification 
at specific sites.  We found that one of these mutations, K86R, resulted in the specific loss of the 
small colony variant subpopulation.  This mutation also resulted in altered gene expression in 
late stationary phase, a stress condition.  These results suggest a model in which modification of 
hupB heritably alters gene expression in a subpopulation of cells that form small colony variants 
in the presence of drug. 
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3.2 Introduction 
 
 Phenotypic heterogeneity has been observed in a wide variety of bacteria.  In M. 
tuberculosis, phenotypic heterogeneity likely contributes to the failure of infection control by either 
the immune system or antibiotic treatment.  Although the importance of phenotypic heterogeneity 
has been demonstrated, our knowledge of the molecular mechanisms driving phenotypic diversity in 
bacterial populations is still scarce. 
In chapter 2, we demonstrated a novel form of phenotypic heterogeneity in M. smegmatis 
that is heritable and epigenetically regulated.  A limited number of examples of heritable, epigenetic 
mechanisms that have the potential to drive this form of heterogeneity have been described in 
bacteria.  DNA methylation is the most well-characterized mechanism by which bacterial cells can 
heritably alter gene expression in a subpopulations of cells, and a recent study showed that DNA 
methylation regulates gene expression in M. tuberculosis(Shell et al., 2013).  Another established 
mechanism involves positive feedback loops, as in the lac operon in E. coli.  In eukaryotes, histone 
modifications are widely used to heritably alter gene expression and chromatin structures in 
subpopulations of cells.  Currently, no analogous form of epigenetic regulation has been described 
in bacteria.   However, bacteria, including mycobacteria, do possess DNA binding proteins that 
perform functions similar to those of eukaryotic histones. These nucleoid-associated proteins are 
largely responsible for the maintenance and plasticity of the bacterial chromosome(Kar et al., 2005; 
Luijsterburg, Noom, Wuite, & Dame, 2006; Swinger & Rice, 2004; Wang, Li, Chen, Xie, & 
Zhuang, 2011).    In E. coli, mutation of the nucleoid-associated protein HU results in altered 
nucleoid organization and altered expression of stress-responsive gene HU mutations also affect 
other DNA-dependent processes such as DNA replication, repair and chromosome segregation. 
! ''!
(Chodavarapu, Felczak, Yaniv, & Kaguni, 2008; Huisman et al., 1989; Jaffé, Vinella, & D'Ari, 
1997; Kamashev & Rouvière-Yaniv, 2000; Ogawa, Wada, Kano, Imamoto, & Okazaki, 1989) 
The mycobacterial histone-like protein HupB is a nucleoid-associated protein with a 
unique two-domain structure.  It is homologous to the prokaryotic HU family in its N-terminus and 
the eukaryotic histone H1 in its C-terminus(Mukherjee, Bhattacharyya, & Grove, 2008).  Histone 
H1 is specifically involved in the formation of higher order chromosome structures and DNA 
condensation, indicating that HupB’s C-terminus may give it the capacity to influence nucleoid 
architecture.  Studies have shown that HupB binds DNA with high affinity, with a preference for 
AT-rich DNA that is characteristic of the regulatory regions of ORFs(S. Kumar, Sardesai, Basu, 
Muniyappa, & Hasnain, 2010; Sharadamma et al., 2011).  HupB is an essential gene in M. 
tuberculosis and essential under certain conditions of stringent growth in M. smegmatis.  
We and others have shown that the mycobacterial hupB is modified at lysine and arginine 
residues.  A recent study found that acetylation of hupB alters its ability to bind and compact DNA 
in vitro(Ghosh, Padmanabhan, Anand, & Nagaraja, 2016).  These findings raise the intriguing 
possibility that modification of hupB could drive altered DNA compaction, and thereby alter gene 
expression, in subpopulations of cells.  In this chapter we investigate this possibility. 
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3.3. Results 
HupB is required for the formation of drug resistant colonies in the presence of INH 
 
In chapter 2, we demonstrated that at least two privileged subpopulations, large and small colony 
variants are able to grow in the presence of MIC-levels of INH.  These subpopulations exhibited 
a heritable ability to grow in the presence of drug in the absence of genetic mutation.  The 
heritability of the drug resistance phenotype in the absence of an underlying genetic mutation 
implies that epigenetic factors are likely to govern the formation of these drug resistant 
subpopulations.  HupB is a DNA binding protein that has previously been implicated in growth 
regulation and survival after INH exposure((Lewin et al., 2008; Niki et al., 2012; Whiteford, 
Klingelhoets, Bambenek, & Dahl, 2011). We tested a hupB deletion for its ability to grow in the 
presence of INH.  We found that the hupB deletion resulted in a significant reduction in the 
numbers of small and large colonies formed, despite exhibiting normal growth in media without 
drug (Figure 3.1, 3.6). We wondered whether hupB might drive the formation of these drug- 
resistant subpopulations by regulating gene expression.  We did RNA-seq in the WT vs hupB 
deletion strain and found that the lack of hupB resulted in depression of 77 genes.  We then did 
gene set enrichment analysis (GSEA) and found that the genes that were derepressed in the hupB 
deletion strain significantly overlapped with those that were downregulated in the small colony 
variants, suggesting hupB represses gene expression to drive small colony formation 
(Subramanian et al., 2005).  We also did chip-seq and found that hupB binds at ~800 sites around 
the genome, suggesting that it may regulate gene expression via global nucleoid remodeling as 
opposed to binding to specific promoters of the regulated genes. 
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Figure 3.1 Loss of HupB results in significant reduction of colony formation in the presence  
of INH and alters gene expression A) Wt, HupB deletion, and complemented HupB strains were 
plated on 7h10 plates supplemented with increasing concentrations of INH, and colonies were 
counted after 3-6 days.  B) Fraction of colonies on INH 4 ugh/ml plates/ colonies on 7h10 plates 
without drug C) Volcano plot of RNAseq data of HupB deletion vs WT cultures in late stationary 
phase.  D) Gene set enrichment analysis (GSEA) of genes differentially expressed in the hupBKO 
and genes downregulated >4 fold with a p<.01 in the small colony variants. There is a significant, 
negative correlation between these two sets of genes, suggesting that hupB represses at least a 
subset of the genes that are downregulated in the small colonies. 
 
 
 
 
 
! '*!
HupB is modified at lysine and arginine residues.  
 
The mycobacterial HupB has a C-terminal extension that is unique among eubacterial histone-
like proteins, in that it contains a series of ‘PAKKA’ repeats that are homologous to the 
eukaryotic histone H1 sequence.  Several of the lysines in the C-terminus have been 
demonstrated to be methylated ((Pethe et al., 2002)).  A recent study intriguingly showed that 
hupB is also acetylated at lysine residues, and that acetylation of hupB in vitro alters it’s ability 
to bind and compact DNA (Ghosh et al., 2016). The same group also showed that Eis acetylates 
hupB and that overexpression of Eis alters nucleoid morphology in M. smegmatis. In parallel to 
these studies, we found that hupB is modified at multiple lysine and arginine residues in a whole 
cell proteomics screen (Figure 3.2).  Several of these modification sites were conserved between 
M. smegmatis and M. tuberculosis (Figure 3.2). In order to test the functions of these 
modification sites, we complemented the hupB deletion strain with a series of hupB mutant 
constructs.  We then assessed the levels of protein in each of these mutant strains.  We found that 
several of these mutations resulted in significantly reduced hupB protein levels, making it 
difficult to specifically asses the role of modification at those residues (Figure 3.3).  We 
continued to study the mutants that did not display any reduction in protein levels, including the 
K86R mutant and the R55K mutant (Figure 3.3, 3.4).  We found a phenotype for only the K86R 
mutant (Fig. 3.7, R55K data not shown) and therefore proceeded to further characterize the effect 
of the K86R mutation on hupB function.  We found that the K86R mutation did not alter the 
DNA binding affinity of hupB in vitro (Figure 3.4).  
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T. Bhomick et al, 2014 
 
       
 
 
 
 
 
Figure 3.2. HupB is modified at lysine and arginine residues. A) A whole cell proteomics 
screen identified modified lysine and arginine residues in HupB.  Several of these sites 
overlapped with putative DNA binding regions predicted by the crystal structure of HupB, which 
was solved by T.Bhomick et al.  B) We purified his-tagged HupB from M. smegmatis and 
validated the modification sites.  Shown here is the spectra of the K86 methylated peptide. 
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A. 
 
B. 
Mutant Phenotype on INH HupB protein levels 
K3R yes reduced 
K3Q yes reduced 
K72R no Not tested 
K94R no Not tested 
K86R yes normal 
K86A yes Slightly reduced 
K86L yes Slightly reduced 
R55A Not tested reduced 
R55K no no 
 
Figure 3.3 Assessment of HupB protein levels  and phenotype on INH following mutation of 
HupB modification sites.  A)  We assessed protein levels of HupB point mutants by tagging 
mutants with a his tag and then probing for their levels by western blot.  Several mutations 
resulted in a reduction of HupB levels. A subset of the mutations are shown here.  B) Chart of 
the mutants made, whether they had a phenotype on INH, and their protein levels relative to 
wild-type as measured by western blot. 
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Figure 3.4 K86R mutation does not alter DNA binding affinity. WT and K86R forms of 
hupB were purified from E.coli.  Surface plasmon resonance (SPR) was performed measuring 
the affinity of the protein to a 30 nucleotide oligo.  Displayed binding is normalized to 
background binding to the chip 
 
 
 
 
Figure 3.5. Growth curves. All strains were grown in triplicate and ODs were read on the Via 
II7 plate reader.  Although all strains with the HupB deletion background grew slower than the 
WT strain, there were no significant differences in growth between the WT and mutant 
complemented strains.  
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HupB K86R mutation results in specific loss of small colony variants  
 
Approximately ten percent of the K86 peptide that we characterized showed evidence of a 
modification. This could indicate that either ten percent of hupB in every cell is modified, or that 
different subpopulations of cells have different hupB modification profiles.  In the latter 
possibility, hupB modification could theoretically alter dna binding and nucleoid compaction in a 
subset of cells, thereby diversifying the population into two distinct physiological states. We 
therefore wondered whether modification of HupB could drive the formation of the 
epigenetically regulated drug resistant variants that we discovered in chapter 2.  We grew the 
WT and K86R mutant strains in media without drug and then plated on 7h10 plates 
supplemented with 4 ug/ml INH.  Intriguingly, we found that although the K86R mutant strain 
formed large colony variants at the same rate as the WT, the K86R mutant resulted in the 
specific loss of small colony variants, while forming large colonies at the same rate as WT 
(Figure 3.6)..  This phenotype was not due to a general growth defect of the mutant strain, since 
the K86R mutant strain grew at the same rate as the WT strain in 7H9 media without drug 
(Figure 3.5).   We also did RNA-seq in the WT and K86R mutant strain and again found a 
general depression of gene expression in the mutant (Figure 3.6).  We did GSEA to determine if 
the differentially expressed genes were enriched for genes that were downregulated in the small 
colonies.  Although there was no a significant enrichment, the data again trended toward a 
negative correlation, suggesting that K86 modification may downregulate genes in the small 
colonies (Figure 3.6) 
 The specific loss of small colony variants in the K86R mutant strain suggests that perhaps 
modification of the K86 residue is driving the formation of the small colony variant 
subpopulation.  If this is true, we might expect to see an enrichment of K86 methylation in the 
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small colonies.  We extracted whole cell lysates from collections of small and large colonies in 
duplicate and measured K86 methylation using parallel reaction monitoring (PRM), a data-
dependent form of mass spectrometry quantification.  Using this method, we did not see any 
significant differences in K86 methylation between the large and small colonies (Figure 3.7).  
However, this method is likely not sensitive enough to detect quantitative differences in peptides 
that are of relatively low abundance in whole cell lysates, as the K86 peptide is.  It is also 
possible that K86 methylation is altered at specific sites in the genome in small vs large colonies, 
making the difference difficult to detect using a bulk assay. 
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Figure 3.6.K86R mutation results in the specific loss of small colonies   A) Total colony 
formation in the presence of INH in complemented HU deletion strain complemented with WT 
and K86R mutant. B) Representative plate images. C) Colony tracking over time – top panel, 
WT, bottom panel, K86R mutant.  D) Histograms at day 7 for WT and K86R strains. E) Volcano 
plot of RNA-seq data of K86R mutant vs WT, RNA collected during late stationary phase. F) 
GSEA results of genes differentially regulated in the K86R mutant against genes downregulated 
more than 4 fold in the small colony variants.  The data trend towards a negative correlation of 
between the two gene sets, suggesting that hupB may downregulate genes in the small colonies 
via K86. 
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p>.05 
Figure 3.7 Differences in HupB K86 methylation were not detected between small and large 
colonies.  The peptide containing K86 was targeting in whole cell lysates from small and large 
colonies using parallel reaction monitoring. 
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Role of methylation in small colony formation. 
In order to ask whether methylation of hupB drives small colony formation, we attempted to 
block methylation in two ways.  First, we found that three methyltransferases were upregulated 
in the small colonies in our RNAseq data.  We knocked out one of these, a SAM-dependent 
methyltransferase (MSMEG_6483), and asked whether the loss of this methyltransferase blocked 
small colony formation.  Although the distribution of colony sizes in the knockout looked 
different from that in the WT strain (Figure 3.8A) it was not clear whether small colonies were 
specifically eliminated.  We also used an indirect methylation inhibitor, 3-Deazaneplanocin A 
(DZnep) to attempt to block methylation in M. smegmatis.  This inhibitor has been shown to 
block methylation in eukaryotic cells via inhibiton of S-adenosylmethionine.  In a preliminary 
experiment, adding this inhibitor to plates with INH appeared to result in a specific loss of small 
colonies (Figure 3.8B), which is consistent with our hypothesis.  Future experiments must to 
done to confirm this result. 
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Figure 3.8 Role of methylation in small colony formation A) Distribution of colony sizes in 
the presence of inh after 5 days in the WT and MSMEG_6483 KO strains. B) Quantification of 
numbers of LCVs and SCVs in the presence of DZnep, a S-adenosylmethionine inhibitor.  
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3.4. Discussion 
 
Epigenetic inheritance allows the forces of evolution to act on phenotypic variation, 
resulting in the selection of privileged subpopulations that are uniquely adapted to any given 
environment.  Previously established mechanisms of epigenetic inheritance in bacteria, such as 
DNA methylation and positive feedback loops, typically involve regulation of only one or a few 
genes.  Our findings suggest the existence of a fundamentally distinct form of epigenetic 
regulation in bacteria, whereby modification of a histone-like protein has widespread effects on 
gene expression that are inherited across generations and bifurcates the populations into two 
distinct cell types.  A recent study showed that acetylation alters the ability of hupB to bind and 
compact DNA, suggesting a plausible mechanism by which these changes in gene expression 
could be implemented(Ghosh et al., 2016).  This form of heritable epigenetic regulation mirrors 
the role of histone modifications in eukaryotes, and is the first indication that an analogous 
mechanism may exist in bacteria.  Intriguingly, histone modifications were recently shown to 
drive the induction of a reversibly drug tolerant state in subpopulations of cancer cells, 
suggesting unexpected parallels of drug survival strategies across these distant cell types(Sharma 
et al., 2010). 
Here we show that while HupB is required for formation of both small and large colonies, 
the K86 residue is solely required for the formation of the small colonies. Though the large 
colonies also appear to be an antibiotic resistant subpopulation that is dependent on the presence 
of HupB, the precise signals that drive their formation are unknown.  Since the K86R mutation is 
not sufficient to drive large colony formation, the lack of methylation at this residue is unlikely 
to be the sole driver of large colony formation.  In future work it would be interesting to 
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determine whether the posttranslational modifications we observed at additional residues in 
HupB are playing are role in the formation of the large colony subpopulation.  Additionally, we 
have not ruled out that DNA methylation plays a role in the formation and maintenance of these 
colony phenotypes.  In eukaryotes, histone modifications have been shown to work in concert 
with DNA methylation implement and maintain gene expression changes across generations.  It 
would be interesting in future work to determine whether there is cross-talk between hupB 
modification and DNA methylation in mycobacteria.  
The mechanism by which modification of hupB could alter gene expression of a subset of 
genes in a subpopulation of cells is as yet unknown.  In eukaryotes, it is well established that 
histones can package chromosomal DNA into domains of varying compaction and transcriptional 
activity.  Similar structural and functional organization of the bacterial nucleiod has more recently 
begun to be appreciated(Dame, 2005; Dillon & Dorman, 2010).  Domains of varying superhelicites 
and levels of gene expression have been described in bacteria, and these domains are highly plastic 
in response to changing environments and growth phases.  In E. coli, mutation of the nucleoid-
associated protein HU results in altered nucleoid organization and altered expression of stress-
responsive genes(Luijsterburg et al., 2006; Oberto, Nabti, Jooste, Mignot, & Rouviere-Yaniv, 
2009). Whether modification of hupB can specifically alter nucleoid organization around specific 
domains, thereby affecting gene expression of a subset of genes, is yet to be explored.    
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3.5 Materials and Methods 
Construction of HupB deletion and mutant strains. HupB deletion strain was constructed 
using previously published protocols to make unmarked deletion mutants.  The complement 
constructs were made in pjEB402.  The hupB ORF and 200 bp upstream of the ORF were 
amplified with primers and cut with XbaI and HindII, and ligated into a pjeB402 vector cut with 
the same enzymes.  Mutations were made by doing site-directed mutagenesis PCR using pfu 
Ultra II HS polymerase. 
INH plating assays.  Cultures were grown overnight from single colonies in triplicate in 5ml 
7h9, shaking at 37 degrees.  The next day cultures were all normalized and grown overnight 
again to an OD ~1.0.  Cells were diluted as indicated and 100 ul aliquots were plated on 7h10 
plates supplemented with OADC (Middlebrook) with or without INH at indicated 
concentrations. 
HupB purification.  His-tagged hupB was expressed in M. smegmatis in pjeb under its native 
promoter and the recombinant strain was grown in 1 L of 7H9 with 25ug/ml of kanamycin to an 
OD of ~1.0.  Cells were pelleted for 10 min at 4000 rpm, and pellets were resuspended in lysis 
buffer (200 mM NaCL, 50 mM Tris-HCL, ph 7.9, .1 mM EDTA, .1 mM DTT, 5% glycerol). 
Cells were lysed using a french press, then centrifuged for 10 min at 10,000.  Supernatant was 
added to cobalt beads (TALON)  that were washed 5x in wash buffer (50 mM Tris-HCL, ph 7.9, 
0.1 mM EDTA, 500mM NaCL, 10 mM imidazole) and rocked overnight at 4 degrees.  Beads 
were then spun down at low speed and liquid was removed, then beads were washed 3x for 10 
min in wash buffer.  HupB was eluted with 1 mL of elution buffer (50 mM Tris-HCL, pH 7.9, 
0,1 mM EDTA, 400 mM NaCl, 500 mM imidazole).  Eluate was mixed with 2x tricine SDS-
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PAGE buffer (Life technologies) and run on a 10-20% tricine gel (Life technologies). Band was 
cut out and gel band mass spectrometry was performed. 
Parallel Reaction monitoring (PRM) Collections of small and large colonies were picked from 
7h10 plates containing 4 ug/ml INH in duplicate.  Cells were resuspended in lysis buffer (200 
mM NaCL, 50 mM Tris-HCl, pH 7.9, 0.1 mM EDTA, 0.1 mM DTT, 5% glycerol) added to glass 
beads and bead beat 6x at max speed for 30 sec each.  Samples were placed on ice in between 
each bead beating cycle for 2 min. Beads were then spun down at 4000 rpm for 5 min.  
Supernatant was taken off the beads and mixed with an equal volume of 2x SDS page sample 
buffer and boiled for 2 min at 98 degrees.  25 ul of  samples were run on 10-20% tricine gel (Life 
technologies) Gel was run for ~15 min at 105 V.  Samples were cut out of gel and sent for PRM 
processing. 
Chip-Seq M. smegmatis expressing hupB-his at an integrated promoter was grown to log phase.  
Chip-seq was performed as described in (Jaini et al., 2014).  The monoclonal his antibody from 
Novagen was used for the pulldown.  Libraries were constructed with the Illumina Tru-seq kit.  
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3.1 Abstract 
  M. tuberculosis is able to effectively adapt to a wide variety of harsh environmental 
conditions.  This ability allows Mtb to establish chronic infection and also resist antibiotic 
treatment.  The molecular mechanisms by which Mtb can withstand these conditions are not 
well understood, and developing a greater understanding of these mechanisms can inform the 
development of improved anti-tuberculosis treatments.  Bacterial nucleoid-associated proteins 
have the ability to drive global transcriptional changes in response to the environment, and are 
therefore prime candidates for facilitating adaptive cellular programs during infection.  In this 
chapter we investigate the function and post-transcriptional regulation of one nucleoid-
associated protein, hupB, in mycobacteria.  We show that hupB is important for survival of M. 
smegmatis in response to both isoniazid and rifampin treatment.  We then investigate two 
potential mechanisms by which hupB function may be regulated in response to a changing 
environment.  We show that hupB is modified, and test the hypothesis that modification of 
hupB drives autoregulation of the hupB promoter.  We then tested the hypothesis that 
processing of the hupB transcript regulates hupB function by creating two protein isoforms of 
hupB.  )
)
)
)
)
)
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3.2 Introduction 
The remarkable ability of M. tuberculosis to tolerate stress contributes significantly to its 
global disease burden.  M. tuberculosis is phagocytosed by alveolar macrophages, where it is able to 
reside for extended periods by evading host immunity.  In the majority of patients, collections of 
immune cells will form around the infected macrophages, forming a granuloma lesion.  M. 
tuberculosis can survive within these lesions for many years, and these latent infections can reactivate 
to cause disease9. Within the granuloma, M. tuberculosis is exposed to a variety of environmental 
stressors including hypoxia, nutrient deprivation, and low pH(Browning, Grainger, & Busby, 2010). 
Furthermore, treatment of tuberculosis can take six to nine months, after which not all infections are 
fully cleared.   This extended treatment time may be attributed in part to the emergence of bacteria that 
can tolerate drug treatment(Adams et al., 2011; Chao & Rubin, 2010). M.tuberculosis’ ability to adapt 
during chronic infection and antibiotic treatment is often attributed to metabolic and transcriptional 
reprogramming in response to stress, but we have a limited understanding of the molecular 
mechanisms that underlie these responses.  
Bacterial nucleoid-associated proteins have the capacity to implement global cellular 
changes in response to the environment. In eukaryotes, it is well established that histones can package 
chromosomal DNA into domains of varying compaction and transcriptional activity.  Similar 
structural and functional organization of the bacterial nucleiod has more recently been 
demonstrated(Dame, 2005; Dillon & Dorman, 2010; Kar et al., 2005; Luijsterburg et al., 2006; Wang 
et al., 2011).  Domains of varying superhelicites and levels of gene expression have been described in 
bacteria, and these domains are highly plastic in response to changing environments and growth 
phases. In addition to regulation of these distinct domains, non-specific, global changes in chromatin 
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compaction in response to stress have also been shown in bacteria.  Imaging of the mycobacterial 
nucleoid has shown strong growth phase and nutrient-dependent changes in chromosomal 
organization(Ghatak, Karmakar, Kasetty, & Chatterji, 2011).   Nucleoid-associated proteins are largely 
responsible for the maintenance and plasticity of the bacterial chromosome(Berger et al., 2010; 
Swinger & Rice, 2004).  In E. coli, mutation of the nucleoid-associated protein HU results in altered 
nucleoid organization and altered expression of stress-responsive genes(Luijsterburg et al., 2006; 
Oberto et al., 2009). HU mutations also affect other DNA-dependent processes such as DNA 
replication, repair and chromosome segregation(Chodavarapu et al., 2008; Huisman et al., 1989; Jaffé 
et al., 1997; Kamashev & Rouvière-Yaniv, 2000).  The diverse effect of these proteins on cellular 
processes makes them uniquely suited to rapidly institute global responses to changing environments. 
The mycobacterial histone-like protein HupB is a nucleoid-associated protein with a unique 
two-domain structure. HupB is an essential gene in M. tuberculosis and essential under certain 
conditions of stringent growth in M. smegmatis.  A number of studies point to a specific role for HupB 
in mycobacterial stress responses.  HupB is upregulated after exposure to host infection, cold shock, 
dormancy, and during stationary phase(M. Kumar et al., 2011; Ogawa et al., 1989; Shires & Steyn, 
2001). Deletion of HupB in M. smegmatis results in increased susceptibility to antibiotic treatment and 
UV exposure(Whiteford et al., 2011).  HupB may also play a role in regulation of the viable but non-
culturable state (VBNC). The VBNC is a state in which the bacteria are nonreplicating and not 
culturable on standard nutrients, but able to be resuscitated by the application of “resuscitation 
factors”.  Although its significance is controversial, VBNC may be a model for the state of Mtb in the 
host during latent infection(Chao & Rubin, 2010).  M. smegmatis HupB deletion strains enter the 
VBNC state significantly later than wild-type strains, and then become irreversibly non-culturable.    
Overall, these findings suggest that HupB plays a critical role in the mycobacterial response to stress. 
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Posttranscriptional regulation of HupB would allow for rapid responses to environmental 
changes.  Although HupB has been shown to be important for survival under different conditions, the 
mechanisms by which its activity may be regulated in response to the environment are not known.   
This proposal focuses on two potential mechanisms of hupB regulation, posttranslational modification 
and RNA processing.   
 In eukaryotes, it is well established that histone modifications, such as methylation and 
acetylation, promote changes in gene expression in response to environmental signals. However, an 
analogous mechanism in prokaryotes is unknown.  Mass-spectrometry data suggests that HupB is 
modified at multiple lysine residues (Figure1), raising the question of whether these modifications 
could give mycobacteria the capacity to similarly regulate cell state.  Aim 1 investigates the functional 
significance of these modifications. 
RNA processing is a similarly novel form of prokaryotic gene regulation.  Alternative 
splicing in eukaryotes frequently creates different protein isoforms from a single gene.  In bacteria, it 
is generally assumed that each gene encodes one protein.  Surprisingly, genome-wide mapping of 
transcript 5’ ends in M.tuberculosis revealed abundant RNA processing events both within coding 
sequences and in intergenic regions (Scarlet Shell, Fortune lab).  Though previous work has identified 
the function of at least one intergenic processing event in mycobacteria, the significance of processing 
events within genes has not been investigated(Sala, Forti, Magnoni, & Ghisotti, 2008).  Intriguingly, 
the global 5’ end mapping suggested that the hupB transcript is cleaved in between the coding 
sequence for the N- and C-terminal domains.  This observation raised the exciting possibility that 
RNA processing of the hupB transcript could create two functionally distinct protein isoforms.  In the 
second part of this chapter, we investigats this possibility. 
‘ 
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3.3 Results 
HupB is posttranslationally modified at lysine residues 
 
Mass spectrometry data suggested that HupB is posttranslationally modified at lysine residues, 
with either methylation or acetylation (Figure 4.1).  Since these modifications are largely conserved 
between M. tuberculosis and its non-pathogenic relative, M. smegmatis, we investigated the function 
of these modified sites in M. smegmatis. I mutated the indicated lysines to arginine, which prevents 
acetylation of the residue while conserving its positive charge.    Since it was previously 
demonstrated that deletion of HupB reduced survival in the presence of isoniazid (ref), I plated the 
mutants on subinhibitory concentrations of isoniazid.  I found a survival defect for the K3 mutant 
only (Figure 4.2).  I also mutated the K3 site to glutamine, which is purpoted to mimic acetylation, 
and saw the same survival defect (Figure 4.2).  This defect was also apparent after plating on 
rifampicin, a distinct class of antibiotic, suggesting that the phenotype is a result of a defect in a 
general stress response pathway. 
 
 
 
 
      with Mike Chase and Alejandra Garces 
 
Figure 4.1. Lysines, including K3, of HupB are modified. A) Proteomics identified 
modified lysine residues in HupB.  Whole cell experiments were done with global protein 
extracts from log phase cultures.  Pull down experiments were done with purified his-
tagged HupB from M. smegmatis 
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Figure 4.2. Mutation of K3 to arginine or glutamine results in significantly reduced 
tolerance to A)isoniazid and B) rifampicin.  Cells were grown in 7h9+kan, normalized to an 
OD of 1.0 then diluted by 1x10-7 and 1x10-4 and plated on either 7H10 or 7h10 + drug, 
respectively.  Colonies were counted after 4 days, and plating efficiency was calculated by taking 
the ratio of colonies grown on drug/number without drug. 
 
 
The K3R mutation results in reduced hupB protein and hupB transcript levels 
The K3 mutant appeared to phenocopy the hupB deletion (Figure 4.2).   We therefore 
decided to look at the expression level of the mutant protein to determine if the reason for the 
defect was lowered hupB levels.   We tagged the wild-type and mutant strains with a his tag and 
probed for protein abundance by western blot. We found that in fact, both the K3R and K3Q 
mutant proteins had significantly reduced protein levels relative to wt (Figure 4.3). To test 
whether the lowered protein levels in the K3 mutants was due to reduced protein stability or 
differences in transcript abundance or stability, we did qPCR of HupB in the wild-type and 
mutant strains. 
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Figure 4.3.  Mutation of K3 lowers HupB protein levels. A) Western blot indicates that K3R 
and K3Q mutations result in lower abundance of his-tagged HupB.  B) Coomassie staining 
demonstrates that these mutations do not affect global protein levels. 
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Figure 4.4. Mutation of K3 lowers HupB transcript levels. Total RNA was extracted from 
WT and K3R log phase cultures, then cdna was made and probed with SYBR green for qPCR.   
 
 
 
 
HupB does not regulate its own promoter via K3  
 
Surprisingly, qPCR revealed that the K3R mutant transcript was also lowered relative to 
the wild-type transcript.  Since we had expressed both the wt and mutant transcript from the 
native hupB promoter, this result raised the intriguing possibility that the K3 mutant was 
negatively autoregulating its own promoter.  However, the alternative possibility was that the K3 
mutant transcript had reduced stability relative to wild-type.  To distinguish between these 
possibilities, we episomally expressed his-tagged wt and K3R HupB mutants under the Tet 
promoter, and then probed for the native hupB transcript with qPCR.  We reasoned that if the 
K3R mutation autoregulates its own promoter, reducing transcript levels, then protein levels of 
the his-tagged hupB expressed under the tet promoter should not differ between the WT and 
K3R mutant.  Additionally, the native HupB transcript levels in the strain overexpressing the 
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K3R hupB mutant should be reduced.  Alternatively, if the hupB k3R mutant transcript is 
directly destabilized, then the protein levels of the hupB K3R mutant expressed from the tet 
promoter should be lowered relative to wild-type. 
The episomally expressed K3R mutant protein levels were reduced relative to episomally 
expressed wild-type HupB.  Furthermore, when we probed for the native transcript in these 
strains, I found that the strain expressing the K3R mutant from the tet promoter had increased 
native transcript levels relative to the wild-type strain. A caveat to this experiment is that 
overexpression of the wt but not the K3R mutant inhibits bacterial growth – and this is likely 
why the transcription in the wt strain is reduced relative to the mutant.  Regardless, the results do 
not support the autoregulation hypothesis.   Therefore, the K3R mutation likely reduces hupB 
transcript stability and does not cause autoregulation of its own promoter. 
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Figure 4.5.  Opposing models for hupB regulation.  In the first model, hupB autoregulates is 
own promoter via K3.  If that is true, then expression of the K3 mutant protein from an episomal 
tet promoter will result in lowered levels of the native hupB transcript.  In the second model, the 
K3 mutant protein is destabilized.  In this model, the mutant protein levels expressed from the 
episomal promoter will be lowered relative to WT. 
 
 
 
 
 
 
 
 
 
 
 
 
! *%!
 
 
 
 
Figure 4.6.  Protein levels of hupB K3R from the tet promoter are lowered relative to wild-
type.  Cultures were induced with 50 ng/ml tet and protein was extracted 60 and 90 minutes 
post- induction. Western blots were probed with an anti-his antibody.  Biological duplicates are 
shown.  A) Western blot indicates that protein levels of the K3R mutant are lowered relative to 
wild type.  B) Coomassie loading control 
 
 
 
 
 
 
 
Figure 4.7.  Native HupB transcript is upregulated in the tet-K3R strain relative to wild-
type. 
Cultures were induced with ATC, and RNA was extracted 3 hours post-induction. Relative 
expression of native hupB was quantified with qPCR . 
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The hupB transcript is processed. 
 Mycobacteria, unlike all other bacteria, have a sole, unique homolog to the prokaryotic 
HU protein, with a C-terminal extension that is homologous to the eukaryotic histone H1.  This 
C-terminal extension may allow mycobacteria to tolerate extreme environmental stress(Salerno 
et al., 2009).  Thus, regulation targeting the C-terminal domain might give mycobacteria the 
flexibility to tune their physiology to different metabolic states.   In light of its unique domain 
arrangement, RNA processing presents a potentially exciting mechanism of HupB regulation.  
Intriguingly, global 5’ end mapping in M. tuberculosis revealed RNA processing sites that were 
clustered in the 3’end of the hupB transcript (Figure 4.8).  Using 3’RACE and qPCR, we 
confirmed that a truncated hupB transcript encoding only the N-terminal HU domain exists in the 
cell (Figure 4.9, 4.10).  The qPCR data suggests that the 3’ end of the transcript is degraded after 
the initial cut. We also did a northern blot that seemed to further suggest the existence of a 
truncated transcript, albeit the signal was weak (Figure 4.11).  
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           Scarlet Shell 
Figure 4.8. 5’ end mapping reveals processing sites in the hupB transcript. Processed 5’ ends 
were distinguished from transcriptional start sites (TSS) by taking advantage of the difference in 
5’ phosphorylation status between these two types of transcripts.  TSS’s have  5’ triphosphates, 
while processed transcripts have 5’ monophosphates.  For one library, the 5’ triphosphates were 
enzymatically converted to monophosphates so that rna adaptors for 5’RACE could be ligated to 
all the 5’ ends; this library would then contain TSS and processed 5’ ends. In the second library, 
5’RACE was done without first converting the 5’ triphosphates.  Since only 
monophosphorylated 5’ ends can be ligated to the adaptor, this library would yield only the 
processed 5’ ends.  5’ ends were called processing sites if the mean ratio of their abundance in 
the converted/non-converted library was near 1.  
 
 
Figure 4.9. 3’RACE reveals the presence of a truncated hupB transcript encoding only the 
N-terminal HU domain.  RNA was extracted from log phase cultures, and an adaptor was 
ligated to the 3’ ends of the transcripts.  Reverse transcription was then performed with a primer 
complementary to the adaptor sequence.  PCR was done on the resulting cDNA, with the 
forward primer annealing to the beginning of the hupB transcript, and the reverse primer 
complementary to the adaptor.  RT- reverse transcriptase, NT- no template control 
! *(!
 
 
 
 
Figure 4.10. Expression of the 3’ end of the hupB transcript is reduced by ~30% relative to 
the 5’ end. qPCR was done with primers to the 5’end, primers spanning the processing site, and 
primers to the 3’end.  Experiments were performed with biological duplicates and technical 
triplicates. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11. Northern blot of hupB.  M. tuberculsosis  was grown to log phase, total RNA was 
extracted and hybridized to a membrane and antisense probes to the N-terminus of the hupB 
transcript were used to detect native hupB forms. 
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Test the hypothesis that RNA processing of HupB creates 2 distinct proteins. 
 The preliminary 3’ RACE data suggests that a truncated hupB transcript encoding only the N-
terminal HU domain exists in the cell, raising the exciting possibility that RNA processing could 
create two distinct proteins from the same coding sequence.   To investigate this possibility, we 
tagged hupB at the N-terminus with a flag tag and looked for evidence of two protein isoforms.  
Although I occasionally saw what looked like two protein isoforms, the results were not consistent 
across blots (Figure 4-12, data not shown).  One explanation for the inconsistency of the results we 
observed is that processing of the hupB transcript varies with slight changes in culture conditions.  
More experiments will have to be done to directly test this hypothesis.  However, we also tagged 
several additional proteins that contained RNA processing sites to ask if the creation of protein 
isoforms was a widespread event in mycobacteria, and we did not see any evidence of protein 
isoforms for the candidates we studied (data not shown).  
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Figure 4.12. Western blot of flag-tagged hupB. hupB is tagged at the N-terminus with a flag tag. 
Flag-tag protein was purified from log phase M. tuberculosis cultures and run on an SDS-PAGE 
gel.   
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3.4 Discussion 
 In this chapter we investigated two mechanisms of post-transcriptional regulation of hupB.  
We found that hupB is post-translationally modified at lysine residues, and that mutation of one of 
these residues, K3, led to reduced protein and transcript levels.  We showed that these effects are 
not due to an autoregulatory loop.  We also tested the hypothesis that processing of the hupB 
transcript leads to the creation of two protein isoforms of hupB.  Though we had evidence that a 
truncated hupB transcript, encoding only the N-terminal domain, was present, we did not find 
convincing evidence that the truncated transcript encoded protein.  Importantly, the truncated 
transcript did not contain a stop codon.  The lack of a stop codon can trigger the recruitment of the 
tmRNA system,, which monitors translational progress through the ribosome.  In the event of a 
stalled ribosome, the tmRNA, which acts as both a tRNA and an mRNA, enters into the A site of 
the stalled complex and tags the incomplete protein product with an ssrA tag, which directs it to 
degradation by the ClpXP protease.  tmRNA recruitment also stimulates release and degradation of 
the abberant transcript.  The tmRNA system has been shown to be triggered by nonstop mRNAs, 
consecutive rare codons, weak termination signals, or depletion of a tRNA during amino acid 
starvation. 
Interestingly, tmRNA deletion strains in model bacteria have been shown to be sensitive to 
stresses that cause protein misfolding, but a link between co-translational protein misfolding and the 
tmRNA pathway has not been established.  Here we found that mutation of hupB leads to reduced 
protein stability and lowered transcript levels.  Since we proved that these effects were not due to an 
autoregulatory loop, this leads to the alternative hypothesis that misfolding of the mutant protein is 
causing degradation of the corresponding transcript via co-translational surveillance of protein 
folding.  In eukaryotes, it has been demonstrated that proteins can fold co-translationally and that 
! *,!
misfolding can trigger ubiquitination and degradation of the proteins.  Additionally, it was just 
recently shown that the transcripts of misfolded secretory proteins can be co-translationally targeted 
for degradation(Karamyshev et al., 2014). However, an analogous mechanism in bacteria has not 
yet been demonstrated. A co-translational surveillance pathway for protein folding in bacteria 
would present a novel first line of defense against the multitude of stresses that can disrupt the 
protein folding environment.  It would be interesting in future work to investigate this possibility. 
! !
! *-!
Materials and Methods 
Construction of HupB deletion and mutant strains. HupB deletion strain was constructed 
using previously published protocols to make unmarked deletion mutants.  The complement 
constructs were made in pjEB402.  The hupB ORF and 200 bp upstream of the ORF were 
amplified with primers and cut with XbaI and HindII, and ligated into a pjeB402 vector cut with 
the same enzymes.  Mutations were made by doing site-directed mutagenesis PCR using pfu 
Ultra II HS polymerase. 
5’ end mapping  5’end mapping was performed as described in (Shell et al., 2015) 
INH plating assays.  Cultures were grown overnight from single colonies in triplicate in 5ml 
7h9, shaking at 37 degrees.  The next day cultures were all normalized and grown overnight 
again to an OD ~1.0.  Cells were diluted as indicated and 100 ul aliquots were plated on 7h10 
plates supplemented with OADC (Middlebrook) with or without INH at indicated 
concentrations. 
Construction of HupB deletion and complemented mutant strains. HupB deletion strain was 
constructed using previously published protocols to make unmarked deletion mutants.  The 
complement constructs were made in pjEB402.  The hupB ORF and 200 bp upstream of the ORF 
were amplified with primers and cut with XbaI and HindII, and ligated into a pjeB402 vector cut 
with the same enzymes.  The his-tag was added with the reverse primer.  Mutations were made 
by doing site-directed mutagenesis PCR using pfu Ultra II HS polymerase. 
3’RACE. An RNA adaptor was ligated to the 3’ends of total RNA using T4 RNA ligase.  RT-
PCR was then performed with a primer complementary to the adaptor sequence to create a 
single-stranded DNA template.  The RT-PCR product was then amplified by PCR with a forward 
primer complementary to the start of the hupB sequence and the RT-PCR primer. 
! +.!
Western blot. N-terminally flag-tagged hupB was expressed from an integrating vector in M. 
tuberculosis.  Recombinant cultures were grown to log phase, protein was extracted and flag-tagged 
proteins were purified by immunoprecipitation and run on an SDS-PAGE gel, then detected with an 
anti-flag antibody. 
qPCR.  RNA was extracted by phenol-chloroform extraction.  cDNA was synthesized using 
superscript III reverse transcriptase (Invitrogen). qpCR was run using iTAQ Universal SYBR green 
Supermix (Bio-RAD). Primers were first tested for efficiency by running a standard curve using 
pre-defined cDNA concentrations. 
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! ! !  CHAPTER FIVE: CONCLUSION 
 
5.1 Epigenetically regulated phenotypic variants in mycobacteria 
)
) Phenotypic diversity enables the survival of uniquely adapted subpopulations in the 
presence of fluctuating environmental stressors.  Though phenotypic diversity can be driven by 
genetic mutation, mutation is an extremely rare event.  In mycobacteria, it is estimated that there 
are 2.4 x 10-10 mutations per base pair per generation.  Still, higher rates of phenotypic variability 
in M. tuberculosis have been observed.  Infection of an individual macaque with a clonal 
population of bacteria generates both sterile and active granuloma lesions, suggesting that 
phenotypic variability in the infecting population can drive the variable course of infection 
observed clinically.  Similarly, persistent subpopulations are able to survive after treatment of a 
clonal population with antibiotics.  These observations suggest that epigenetic factors are likely 
to be a primary driver of phenotypic variability in mycobacteria.  
 Here, we used dynamic and quantitative imaging to show that exposure of M. smegmatis 
to drug results in the selection of at least two distinct phenotypic variants that are able to grow in 
the presence of antibiotic.  These variants form at a much higher rate than would be expected by 
a mutational mechanism, constituting ~3-10% of the total population.  The variants showed an 
increased ability to grow on drug relative to the total population, and they could be distinguished 
by their distinct transcriptional signatures and growth properties. The observation of these 
distinct phenotypic variants at the colony level suggested the intriguing possibility that the 
variant phenotypes are inherited across generations.   Using live-cell imaging we showed that the 
growth properties of the variant types were in fact sustained across generations.  We also showed 
that the increased ability to grow on drug could be inherited across generations before reversion 
to the fully drug-susceptible form.   
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 It is intriguing to note that the survival kinetics of M. tuberculosis in patients immediately 
following treatment with antibiotics are similar to the dynamics that we observed after exposing 
M. smegmatis to increasing concentrations of INH in vitro. Namely, in the first 2 days following 
treatment of patients with antibiotics, approximately 90-99% of the bacteria are eliminated, while 
the last 1-10% of bacteria persist at day 2 and then are more slowly eliminated over time (Jindani 
et al., 2003; Walter et al., 2015).  The persistence of this subpopulation may contribute to the 
prolonged treatment time required to sterilize TB infections, which can last up to 6-9 months.  
We show similar effects when we expose M. smegmatis to a range of INH concentrations in 
vitro.  Although the majority of the population is killed at lower concentrations of drug, 
approximately 1-10% of the population, which consists of the large and small variants, persists 
and is then more slowly eliminated with increasing concentration.  This coincidence raises the 
possibility that slow elimination of Mtb in patients is due to the selection of epigenetically 
regulated phenotypic variants.  In future work, it would be interesting to further explore this 
possibility.   
5.2. Molecular mechanisms driving epigenetic inheritance in mycobacteria  
Previously described forms of phenotypic variation in bacteria have ranged from 
extremely low frequency mutational events to high frequency switches generated during cell 
division (Aldridge et al., 2012).  The form of phenotypic variation described here lies in between 
these two extremes, suggesting that mechanisms of epigenetic inheritance are driving the 
formation and maintenance of these phenotypic variants.  DNA methylation is one mechanism 
by which bacteria can achieve epigenetic inheritance, and a recent study showed that DNA 
methylation occurs in mycobacteria and can alter gene expression(Shell et al., 2013).  However, 
DNA methylation typically regulates one or a few genes.  The phenotypic variants we described 
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exhibit widespread differences in gene expression.  Furthermore, the distribution of the gene 
expression differences across the genome suggest that different nucleoid structure in the different 
phenotypic variants might underlie the transcriptional changes.  In bacteria, nucleoid-associated 
proteins are the primary factors that maintain and alter the structure of the bacterial chromosome.  
HupB is a mycobacterial nucleoid-associated protein that had previously been shown to be 
important for survival in the presence of isoniazid (Niki et al., 2012; Whiteford et al., 2011).  We 
found that deletion of hupB resulted in a significant loss of small and large colony variants.  We 
also found that hupB is post-translationally modified by methylation and acetylation, and that 
mutation of a methylation site of hupB resulted in the specific loss of the small colony variants 
population.  This finding suggests the existence of a novel form of epigenetic regulation in 
bacteria, where modification of nucleoid-associated proteins can drive heritable differences in 
nucleoid structure and gene expression. Variability in the levels of modification across cells 
could thereby drive the formation of phenotypically diverse subpopulations with different drug 
susceptibilities.  Changes in modification state driven by fluctuating environments could also 
regulate  
Other nucleoid-associated proteins (NAPs) in mycobacteria have been shown to affect 
survival in the presence of antibiotics.  Lsr2 is one mycobacterial histone-like protein that has 
been shown to globally regulate gene expression.  Deletion of Lsr2 reduces survival in the 
presence of multiple antibiotics (Colangeli et al., 2007).  Similarly, napM, a newly described 
nucleoid-associated protein regulates the expression of ~150 genes and deletion of napM reduces 
survival in the presence of ethambutol and rifampicin.  Interestingly, in our whole cell 
proteomics screen identified additional NAPs that were post-translationally modified, including 
Lsr2 (data not shown).  This raises the intriguing possibility that post-translational modifications 
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of other NAPs could drive the formation of additional phenotypic variants that are specifically 
adapted to different antibiotics.  Understanding the regulation of these NAPs along with 
elucidating the additional complexities of post-translational modification of hupB will give us a 
greater understanding of the mechanisms by which bacteria can modulate nucleoid architecture.  
This NAP-dependent regulation of nucleoid architecture may be a critical strategy by which 
bacterial populations achieve phenotypic diversity and survival across fluctuating environments. 
5.3 Additional potential mechanisms of hupB post-transcriptional regulation. 
 HupB is unique among bacterial HU proteins because it has an additional C-terminal 
domain that is homologous to the eukaryotic histone H1.  This C-terminal extension may 
increase the affinity of hupB for DNA (S. Kumar et al., 2010; Sharadamma et al., 2011).  We 
found evidence of an RNA processing site in between the two hupB domains from global 5’end 
mapping data.  We subsequently confirmed the existence of two hupB transcripts in the cell.  We 
then tested the hypothesis that processing of the hupB transcript creates two protein isoforms in 
the cell.  Though the results gave some indication of the existence of two protein isoforms, they 
were inconsistent.  One explanation of the inconsistent results may be that processing of hupB 
varies with slight differences in culture conditions.  Condition-dependent processing of the C-
terminal extension of hupB could allow mycobacteria to modulate the affinity of hupB for DNA, 
and perhaps nucleoid architecture, in response to fluctuating environments.  
5.4 Epigenetic drivers of the TB epidemic. 
 Tuberculosis recently surpassed HIV to become the world’s leading infectious disease 
killer, causing approximately 1.5 million deaths per year.   In 2014, 9.6 million people developed 
active TB disease. The extensive variability of infection and treatment outcomes have 
contributed to the intractability of the M. tuberculosis pathogen and hinders the effectiveness of 
! +)!
our current suite of antibiotics. The current drug regimen can last up to 9 months, resulting in 
many patients receiving incomplete treatment(World Health Organization, 2015). Even among 
those who have completed treatment, recurrent infections are common and may occur in up to 
30% of treated cases. Although genetically encoded drug resistance contributes to a portion of 
treatment failures, the high failure rates suggest that epigenetic factors are likely to play a major 
role in driving treatment failures.  Accordingly, it has been shown that strains responsible for 
relapsing often lack genetic mutations(Bryant et al., 2013).    This dissertation describes 
epigenetic mechanisms that may contribute to the observed variability in infection outcomes and 
high percentage of treatment failures.  Understanding these epigenetic drivers of M. tuberculosis 
diversification and survival could help facilitate the improved design of anti-tuberculosis 
therapies in the future. 
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Appendix I. Identification of novel riboswitches in M. tuberculosis 
 
 A riboswitch is a regulatory component of a mRNA, typically located in the 5’utr, which 
binds small molecules and implements changes in transcription or translation of the downstream 
gene in response to binding.  Riboswitches allow for rapid responses to to fluctuating 
environments.  Futhermore, riboswitches may be plausible drug targets, since many antibiotics 
target structural RNAs.  There are two broad classes of riboswitches that have been described.  
The first class consists of translation attenuating riboswitches, where binding of the riboswitch to 
its cognate ligand results in the activation or termination of translation of the downstream ORF.  
Alternatively, transcription attenuating riboswitches regulate transcription of the downstream 
ORF upon binding their ligands. 
 Only one riboswitch has been fully described in M. tuberculosis thus far.  This is the 
vitamin B12 riboswitch, which transcriptionally regulates the metE gene, which encodes a 
methionine synthase(Warner, Savvi, Mizrahi, & Dawes, 2007).    Using the combination of 
genome-wide 5’end mapping and RNA-seq data, we sought to identify novel transcription 
attenuating riboswitches in M. tuberculosis. We reasoned that a transcription attenuating 
riboswitch, if set in the ‘off’ position, would have higher expression than the downstream ORF 
that it regulates.   We therefore defined the 5’end of each ORF with the 5’end mapping data, 
calculated the expression of the first 100 bp following the 5’end, and then compared that to the 
expression level of the rest of the gene.  We reasoned that the greater the difference between the 
first 100 bp with the rest of the gene, the more likely it was that those first 100 bp, or the entire 
5’UTR was acting as a transcription attenuating riboswitch.  Importantly, this technique only 
identifies riboswitches that are in the ‘off’ position in the condition in which the RNA-seq data 
was collected – in this case, in log phase Mtb.  Performing these analyses with RNA-seq data 
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collected from a wide variety of conditions has the potential to more completely define the 
riboswitches in Mtb. 
 We found some interesting candidates for riboswitches after doing this analysis 
(Supplementary figure 6.1).  We followed up on two particular candidates, narG (Rv1161) and 
narK(Rv1737).  These genes are involved in the metabolism of nitrate(Malm et al., 2009; 
Sohaskey & Wayne, 2003). narK is a nitrate transporter, while narG is a nitrate reductase.  
Nitrate metabolism is important for survival during anaerobic conditions, and studies have 
shown that nark and narG are in fact upregulated during hypoxia and during macrophage 
infection (Jung et al., 2013) (Sohaskey & Wayne, 2003).  Intriguingly, mutations in the upstream 
regions of both narG and nark2 have been shown to affect transcription the downstream ORF 
and nitrate reductase activity(Chauhan, Singh, & Tyagi, 2010; Stermann, Bohrssen, Diephaus, 
Maass, & Bange, 2003), consistent with the idea that the 5’UTR is a potential riboswitch.  A 
polymorphism in the narG upstream region distinguishes M. tuberculosis from M. bovis (BCG) 
and correspondingly, differences in expression of narG and nitrate reduction activity between M. 
tuberculosis and M. bovis have been observed(Sohaskey & Modesti, 2009).    
We found that both narG and nark2 were top candidates for riboswitch activity , with 
their UTR’s upregulated relative to their downstream ORFs by ~5 fold and ~14 fold, respectively 
(Notably, narG is in an operon with narGHJI, meaning the riboswitch likely regulates the entire 
operon, but we limited our analysis to the first gene following the transcription start site).  We 
validated the RNA-seq data by doing qPCR (Figure 6.1, narK2 data not shown).  We then 
wondered whether hypoxia might upregulation narG expression via a 5’utr riboswitch. If this 
was true, we would expect that during hypoxia, the ratio of expression between the 5’utr and the 
downstream ORF would be reduced due to either loss of inhibition or activation of the 
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riboswitch, leading to read through of the downstream transcript.  We in fact did see the expected 
reduction in this ratio when we collected RNA from hypoxic conditions (Figure 6.2).  These 
results suggest the possibility of an oxygen-sensing riboswitch, which would be a novel class of 
riboswitches in bacteria.  Further studies must be done to test this hypothesis. 
 
 
Figure 6.1. Expression of the 5’UTR and the ORF of narG, Rv1161 
qPCR confirms RNAseq data
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Figure 6.2.  Ratio of 5’UTR expression relative to the downstream ORF for narG in normal 
vs. hypoxic conditions. 
 
Supplementary table 6.1. List of top riboswitch candidates 
coord_of_tss associated_gene 5'_utr_length ratio 5'utr expression/gene 
4411270 Rv0001 263 183 
104959 Rv0094c 296 58 
4099474 Rv3660c 326 39 
4411177 Rv0001 356 37 
2047600 Rv1806 472 37 
2047594 Rv1806 478 36 
2544383 Rv2270 315 34 
79313 Rv0070c 417 25 
4083020 Rv3644c 299 24 
1165681 Rv1042c 182 22 
678896 Rv0584 333 18 
309839 Rv0256c 292 18 
4083048 Rv3644c 327 17 
706075 Rv0612 249 16 
577169 Rv0488 495 15 
3926504 Rv3507 65 14 
1965571 Rv1737c 201 14 
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Hypoxia promotes readthrough of narG transcript?
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706243 Rv0610c 334 13 
1374266 Rv1230c 69 13 
1347105 Rv1203c 200 12 
3446005 Rv3080c 17 12 
1985024 Rv1753c 249 12 
909581 Rv0815c 263 12 
3725971 Rv3340 156 11 
1298962 Rv1167c 270 11 
2982041 Rv2661c 465 11 
3446041 Rv3080c 53 11 
3545368 Rv3176c 68 10 
1469899 Rv1313c 394 10 
434762 Rv0355c 83 10 
676031 Rv0578c 115 10 
1696858 Rv1507A 498 10 
1735508 Rv1535 468 10 
2226211 Rv1983 33 9 
4400438 Rv3912 432 9 
4322175 Rv3848 151 9 
3540860 Rv3171c 115 9 
74921 Rv0068 380 9 
501057 Rv0415 91 9 
181022 Rv0152c 126 9 
501051 Rv0415 97 8 
1302855 Rv1173 76 8 
1090328 Rv0977 45 8 
361275 Rv0297 59 8 
193358 Rv0162c 223 8 
361265 Rv0297 69 8 
1523934 Rv1355c -98 8 
4052867 Rv3611 83 8 
1545892 Rv1373 120 8 
4052688 Rv3611 262 8 
916423 Rv0822c 112 8 
133845 Rv0111 105 7 
2402719 Rv2142c 209 7 
1935139 Rv1706A 490 7 
3287971 Rv2943 493 7 
3267425 Rv2935 312 7 
3025432 Rv2713 9 7 
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3872851 Rv3450c 355 7 
282641 Rv0235c 27 7 
2397210 Rv2136c 372 7 
532306 Rv0442c 92 7 
468245 Rv0388c 244 7 
3564305 Rv3195 59 7 
3849277 Rv3430c 472 7 
1342979 Rv1199c 374 7 
2498779 Rv2226 53 7 
3945735 Rv3514 59 7 
3005761 Rv2688c 111 6 
3569031 Rv3197A 352 6 
3849290 Rv3430c 485 6 
1078545 Rv0969 198 6 
2632124 Rv2351c 49 6 
1933132 Rv1705c 478 6 
1455270 Rv1299 225 6 
3126479 Rv2818c 335 6 
2800788 Rv2488c -92 6 
4405547 Rv3916c 380 6 
1933138 Rv1705c 484 6 
3972481 Rv3533c 28 5 
3806046 Rv3391 -425 5 
105268 Rv0096 56 5 
612908 Rv0522 130 5 
3795119 Rv3379c 252 5 
3068307 Rv2754c 362 5 
375746 Rv0305c 35 5 
3958096 Rv3522 352 5 
2618971 Rv2340c 63 5 
131340 Rv0109 42 5 
3930950 Rv3508 55 5 
3799988 Rv3386 104 5 
2934953 Rv2608 93 5 
1830902 Rv1628c 341 5 
3423215 Rv3060c 2 5 
271804 Rv0226c 240 5 
1123602 Rv1006 112 5 
714190 Rv0621 12 5 
2966120 Rv2642 413 5 
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412695 Rv0343 62 5 
333417 Rv0277c 281 5 
1287124 Rv1161 204 5 
3877132 Rv3455c 310 5 
3939558 Rv3511 59 5 
92206 Rv0084 122 5 
186429 Rv0158 356 5 
2039833 Rv1800 -380 4 
3886280 Rv3468c 211 4 
538945 Rv0449c 397 4 
3535413 Rv3166c 62 4 
463394 Rv0386 17 4 
1123591 Rv1006 123 4 
1855710 Rv1646 54 4 
1701052 Rv1510 243 4 
1521874 Rv1354c -2 4 
1169280 Rv1046c 52 4 
1701064 Rv1510 231 4 
3494567 Rv3129 93 4 
3985358 Rv3546 199 4 
2562953 Rv2291 221 4 
1371225 Rv1227c 400 4 
1998811 Rv1765c 296 4 
1325686 Rv1184c 75 4 
3784774 Rv3370c 34 4 
2966085 Rv2642 448 4 
3778521 Rv3367 47 4 
3752231 Rv3347c -953 4 
110206 Rv0101 -205 4 
330375 Rv0274 47 4 
3166652 Rv2856 32 4 
2529385 Rv2255c 211 4 
4400809 Rv3912 61 4 
2170139 Rv1918c -473 4 
2062749 Rv1818c 75 4 
1243672 Rv1121 35 4 
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Appendix 2.  RNA-seq in M. tuberculosis across different conditions. 
 
One defining feature of the macrophage environment in which M. tuberculosis lives is its 
lack of carbohydrate nutrients, which forces the bacterium to rely on fatty acid/lipid metabolism 
for growth. Additionally, M. tuberculosis in a macrophage is starved for iron and experiences 
acidic conditions. Global transcriptional responses likely underlie mycobacterial persistence 
under these conditions.  Although microarray studies have been done to assess changes in gene 
expression under different conditions, this experiments were not able to define potentially 
important features of the mycobacterial transcriptome, including noncoding RNAs and 
transcriptional start sites. Here, we used RNA-seq to generate high resolution maps of the 
mycobacterial transcriptome under different metabolic states.  
   We grew M. tuberculosis to log phase in media containing either .4% glucose, .1%     
butyrate, .2% glucose + .1% butyrate, low iron and low pH.  RNA was harvested and  RNAseq 
libraries were made and sequenced with the help of Jonathan Livny (Broad).   
    The data show that global remodeling of the TB transcriptome occurs under these conditions 
(Figure 3.1). We reassuringly saw genes we expected to change in certain conditions, such as the 
upregulation of the mycobactin iron regulatory proteins in low iron.  Additionally, we were able to 
clearly see start sites in the data that lined up with previous 5’end mapping (Figure 3.2).  
Intriguingly, we observed instances of multiple start sites for a given ORF in our RNA-seq data.  A 
systematic analysis of the plasticity of start site usage could provide compelling evidence for start 
site regulation as a key component of transcriptional plasticity. Also, analyzing  the relationship 
between start site usage and  expression of the corresponding ORF might provide insight as to  
whether alternating start sites may function to regulate the expression of the downstream gene. 
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Figure 7.1 Representative volcano plots for High vs Low iron and High vs Low pH. 
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Figure 7.2. Visualization of 5’ends by RNAseq aligns with 5’ end mapping data. A. 
Location of 5’ end from 5’ end mapping data (Scarlet Shell). B. Representation of reads in 
RNA-seq data.  
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